Biofrontera settles patent dispute with Dusa over skin treatment
30-11-2021
English court sides with Eli Lilly in Genentech jurisdictional clash
08-12-2017
RJohn97 / iStockphoto.com
Biotechnology company Genentech has filed a claim against Eli Lilly, alleging that it has infringed a patent relating to a skin treatment.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Eli Lilly, Genentech, US District Court for the Southern District of California, psoriatic arthritis, plaque psoriasis, patent, patent infringement
